RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression

miRNA-17 Members that TargetBmpr2Influence Signaling Mechanisms Important for Embryonic Stem Cell Differentiation In Vitro and Gastrulation in Embryos

(2015) Shannon M. Larabee et al.   STEM CELLS AND DEVELOPMENT

The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy

(2013) Yang Zhao et al.   GYNECOLOGIC ONCOLOGY

De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development

(2013) Patricia C. Sanchez-Diaz et al.   PLoS One

Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration

(2012) Angela Ogden et al.   CANCER AND METASTASIS REVIEWS

MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle

(2012) I-Ping Yang et al.   CARCINOGENESIS

MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells

(2012) Suling Liu et al.   PLoS Genetics

MicroRNAs and the cell cycle

(2011) María José Bueno et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Mechanisms of microRNA deregulation in human cancer

(2011) Shan Deng et al.   CELL CYCLE

Shielding the messenger (RNA): microRNA-based anticancer therapies

(2011) Elena Sotillo et al.   PHARMACOLOGY & THERAPEUTICS

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Identification of MicroRNA-93 as a Novel Regulator of Vascular Endothelial Growth Factor in Hyperglycemic Conditions

(2010) Jianyin Long et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer

(2010) Kyung Sook Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

miRNAs in human cancer

(2010) Thalia A Farazi et al.   JOURNAL OF PATHOLOGY

RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9

(2009) Yang Zhao et al.   GYNECOLOGIC ONCOLOGY

The role of RhoC in growth and metastatic capacity of melanoma

(2009) Barbara Boone et al.   JOURNAL OF CUTANEOUS PATHOLOGY

RhoC Expression and Head and Neck Cancer Metastasis

(2009) M. Islam et al.   MOLECULAR CANCER RESEARCH

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma

(2008) Hideyuki ABE et al.   BIOMEDICAL RESEARCH-TOKYO

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

(2008) Andrea Ventura et al.   CELL

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

(2008) E. J. Nam et al.   CLINICAL CANCER RESEARCH

miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation

(2008) Kara M. Foshay et al.   DEVELOPMENTAL BIOLOGY